M.R. Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 3.01 M
as on 26-06-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
as on 26-06-2024
- Satisfied Charges ₹ 8.15 Cr
as on 26-06-2024
- Revenue 49.56%
(FY 2023)
- Profit 123.98%
(FY 2023)
- Ebitda 165.26%
(FY 2023)
- Net Worth 63.35%
(FY 2023)
- Total Assets 45.24%
(FY 2023)
About M.R. Speciality Chemicals
The Corporate was formerly known as M R Pharma Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 3.01 M.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹8.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Champalal Jain and Pradeepkumar Jain serve as directors at the Company.
- CIN/LLPIN
U24100MH1996PTC100199
- Company No.
100199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at M.R. Speciality Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeepkumar Jain  | Director | 24-May-2006 | Current |
| Champalal Jain | Director | 13-Jun-1996 | Current |
Financial Performance of M.R. Speciality Chemicals.
M.R. Speciality Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.56% increase. The company also saw a substantial improvement in profitability, with a 123.98% increase in profit. The company's net worth Soared by an impressive increase of 63.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M.R. Speciality Chemicals?
In 2023, M.R. Speciality Chemicals had a promoter holding of 93.36% and a public holding of 6.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Mar 2024 | ₹6.00 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Mar 2019 | ₹6.00 Cr | Open |
Others Creation Date: 27 Apr 2023 | ₹6.00 Cr | Satisfied |
How Many Employees Work at M.R. Speciality Chemicals?
M.R. Speciality Chemicals has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.R. Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.R. Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
